The man who hands over a semen sample has usually braced himself for it to be his fault. It's the appointment he has been quietly dreading for months, and he already knows how the conversation goes if the numbers are bad. So when the report comes back with the count fine, the motility fine and the morphology within range, the relief is immediate. He's been cleared. Whatever is going on here, it isn't him.
Then the cycles happen and the numbers don't translate the way he expected. Two IUIs, nothing. An IVF cycle: fourteen eggs, eleven mature, nine fertilise beautifully, and then almost everything stalls between day three and day five. Two blastocysts. One transferred, a positive test, and a loss at seven weeks. And the question on his face is always the same. My test was normal, so how is any of this happening?
This blog is for couples whose semen analysis came back fine and whose cycles keep failing anyway, and for anyone who has been told the male side is ruled out on the strength of a single report. What that report actually measures is genuinely narrower than people assume, and once you see the gap, a test almost nobody orders starts to look a lot less optional.
The report is misleading and always has been, not because the numbers are wrong but because of what they describe. A standard semen analysis is a headcount and a swimming test:
It says nothing whatsoever about the cargo. Every sperm carries a tightly wound set of chromosomes, and that DNA can be nicked, broken or oxidised in ways that change nothing about how the sperm looks down a microscope or how fast it swims. A sperm with badly fragmented DNA can be a fast, perfectly formed, textbook specimen. It will reach an egg. It will fertilise it. The problem arrives later.
Most of this damage comes from oxidative stress, and crucially, much of it happens after the sperm has been made, during the couple of weeks it spends maturing and waiting in the epididymis. That's why the usual culprits are the ones they are:
So the semen analysis came back normal. That sounds like the male side being cleared. It usually isn't the clearance it looks like.
The two things diverge more often than anyone expects. A meaningful share of men with entirely normal conventional parameters turn out to have high DNA fragmentation when somebody bothers to measure it.
What matters clinically is where the damage surfaces, because it isn't at the beginning. Fertilisation usually proceeds normally, particularly with ICSI, which bypasses the natural selection step altogether and injects a sperm chosen on appearance. The paternal genome only really switches on around day three of embryo development. So fragmentation tends to announce itself late:
That last association is now reflected in the guidance. In its first revision of the recurrent pregnancy loss guidance in fourteen years, ASRM stated that sperm DNA fragmentation testing may be considered in patients with otherwise unexplained recurrent miscarriage. That's a cautious sentence, and deliberately so, but it's a considerable shift from where the field sat a decade ago.
A semen analysis tells you how many showed up and how well they swim. It tells you nothing about what they're carrying.
Misattribution, and it is expensive in a way that doesn't show up on any invoice.
When nobody looks at the male side beyond the first report, the failures get assigned to her by default. More tests on her. Immune protocols. Endometrial investigations. Another retrieval, then another, each one aimed at the half of the couple whose file is already thick, while a two-page report from eighteen months ago sits in the notes marked normal.
That costs money and it costs cycles, but mostly it costs time, and time in this context is her ovarian reserve. A year spent investigating the wrong partner is a year she does not get back.
When couples ask why we want a further test on a man whose first test was fine, this is the answer. The male side doesn't need to be cleared once. It needs to be looked at properly when the pattern points that way.
This is the part almost nobody gets explained, starting with the most important caveat.
This is not a screening test. The AUA and ASRM guideline states plainly that clinicians should not recommend DNA fragmentation analysis in the initial evaluation of an infertile couple, and that position is reasonable. It earns its place as a second-line test, when the pattern calls for it:
The test itself comes in several forms, SCSA, TUNEL, Comet and sperm chromatin dispersion among them, each with its own threshold and none accepted as a gold standard. Broadly, a fragmentation index above the mid-twenties to thirty percent is where most laboratories draw the line. Results are not interchangeable between labs, so a result should be interpreted against the threshold of the lab that produced it, and repeated in the same place.
Abstinence matters more than most men are ever told. Because damage accumulates during storage, a long abstinence period inflates the figure. Shortening it to a day or two, and in some protocols collecting a second sample within hours of the first, can drop fragmentation substantially with no treatment at all.
Then there is treating the cause rather than the number. A varicocele can be repaired. An infection can be treated. Weight, smoking, alcohol, heat exposure and blood sugar are all modifiable. Antioxidant supplements are the popular answer here and the evidence for them is considerably weaker than the marketing, so they are not a substitute for finding out what is actually driving the oxidation. In the lab, sperm selection techniques that sort for less damaged sperm are plausible and increasingly used, though the evidence behind them remains thinner than anyone would like.
If your doctor proposes a minor procedure to retrieve sperm directly from the testicle, in a man whose ejaculate contains millions of them, this sounds completely backwards. It is one of the better-supported moves in this entire area.
The logic follows from where the damage happens. Since much of the fragmentation is acquired after the sperm leaves the testicle, sperm taken directly from the testicle carries markedly less of it, with pooled analyses showing a difference of roughly twenty-five percentage points. When that testicular sperm is used for ICSI in men with confirmed high fragmentation, meta-analyses report:
The benefit is clearest in exactly the man described at the start of this article: normal semen parameters, high fragmentation, and at least one failed ICSI cycle behind him.
It isn't a first move. It's a surgical procedure, however small, and the underlying studies are mostly non-randomised. But it is the reason confirming fragmentation can genuinely change a plan rather than simply adding a worrying number to a file.
He is 41. Semen analysis normal on two separate occasions. Two failed transfers of good-quality blastocysts and one loss at seven weeks. Fragmentation testing comes back at thirty-four percent. A scrotal examination, which nobody had actually performed, finds a varicocele.
Three months of work follows:
A repeat test comes back at twenty-two percent. The next cycle runs with a short abstinence sample and lab selection, and if that cycle fails in the same pattern, testicular retrieval is the next conversation rather than a fourth round of tests on her.
That is a good sequence. It won't feel like one, because it adds three months to a process that already feels endless. But three months spent on the half of the couple nobody had examined beats another retrieval aimed at the wrong problem.
The three months are not arbitrary either. Sperm takes roughly seventy-four days to make, so anything he changes takes about two and a half months to appear in a sample. Retesting in three weeks to see whether the supplements are working will tell you nothing except that three weeks have passed. Start early, change the things that actually drive oxidation, get properly examined rather than assumed normal, and give the biology the time it needs to show you an answer.
A normal semen analysis is a genuinely good sign, and it is not a clearance. It measures the arrival and the journey, not the message being delivered, and the difference between those two things is where a proportion of failed cycles and early losses quietly live. The male half does more, not less, than one report suggests. Ordering the test when the pattern calls for it, treating the cause rather than the number, and the willingness to consider testicular sperm aren't minor details. They separate a couple who found the answer from a couple who spent three more years looking on the other side of the room.
Stop treating one normal report as the end of the male investigation. Book a consultation at MMC IVF and have both halves of this looked at properly. Book Now
Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support.
MMCIVF and Zivanza Wellness are trademarks and tradenames owned by MUrgency Inc., USA.
Services listed on the MMCIVF.com website are available in each Country we provide services in through MMCIVF Affiliated Clinics licensed, regulated and supervised by the Competent Authorities in the respective Country and based on the applicable laws, rules and regulations in the respective Country / Jurisdiction.
MMCIVF operates Clinics in each Country as aforesaid above under the laws, rules and regulations of the respective Country. All patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Clinics and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents are expected to be fully compliant with the laws, rules and regulations in the respective Country and of any other jurisdiction they (the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents) are subject to. MMCIVF Country / MMCIVF Country Directors / MMCIVF Country Doctors / MMCIVF Country Nurses / MMCIVF Country Staff / MMCIVF Country Agents cannot and will not take any responsibility and / or liability for compliance or non-compliance of any law, rule or regulation outside the respective Country where treatment is sought and provided which is solely the responsibility of the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents.
Further, MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents will not solicit and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India to Indian Citizens / Residents (whether in India or outside India) strictly following this as MMCIVF Country policy recognizing and respecting applicable Indian Laws, Rules, and Regulations. All Indian Citizens / Residents are advised to ensure that they fully comply with the applicable Indian Laws, Rules, and Regulations while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. MMCIVF Country shall not take any responsibility whatsoever for any violation of any applicable Indian Laws, Rules, and Regulations by any Indian Citizen / Resident while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country which sole responsibility shall vest with such Indian Citizens / Residents reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. In case any individual / agency / firm / company reaches out to any Indian Citizen / Resident for and on behalf of MMCIVF Country for any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India, please be known that we have not authorized any staff member / individual / agency / firm / company to reach out to Indian Citizens / Residents (whether in India or outside India) to offer and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India. If you are aware of any such reach outs and / communication, please inform MMCIVF Country at info@mmcivf.ae immediately so that we can take remedial measures against such reach outs claiming to represent MMCIVF Country.
Further, MMCIVF in each Country operates independently and separately from other MMCIVF Clinics in Other Countries.
NOTE: Please read Country as respective Country – USA, Kenya, Georgia and United Arab Emirates as appropriate, relevant and applicable.